ICU patients on probiotics might be more prone to Lactobacillus bacteremia.
The penultimate sentence in a recent research letter in Nature Medicine captures what most people have heard about probiotics: “Probiotics have shown significant benefits for acute infectious diarrhea, antibiotic-associated diarrhea, and ulcerative colitis.” But it’s the last sentence in the letter that garnered headlines like this today-“When 'Friendly' Probiotic Bacteria Turn Into Foes In The ICU.”
In that last sentence, investigators at Boston Children’s Hospital write that “our findings highlight that as ICU patients have increased risk for probiotic-associated bacteremia, these potential benefits must be weighed against this risk when considering the continued use of probiotics in the ICU.”
The risks are substantial, too, according to investigators: ICU patients on probiotics are 120 times more likely to develop Lactobacillus bacteremia, a bloodstream infection.
Some strains ofLactobacillus-such as Lactobacillus rhamnosus-are what make probiotics a health enhancer, for the most part. However, the research letter states that Lactobacillus rhamnosus can morph into Lactobacillus bacteremia. Investigators did this by collecting “genomics data that support the idea of direct clonal transmission of probiotics to the bloodstream.”
Then it becomes a superbug, resistant to most antibiotics. “Our findings support that probiotic strains can directly cause bacteremia and adaptively evolve within ICU patients,” the research letter states.
Greg Priebe, MD, one of the authors of the research letter, told WBUR, the public radio station in Boston, that Boston Children’s Hospital eventually banned probiotics in 2017 for ICU patients who are being treated intravenously.
An epidemiological analysis was conducted over 5 yearsof 22,174 patients who were treated in an ICU, and 522 of those patients received the Lactobacillus rhamnosus strain GG (LGG) probiotics-typically through a feeding tube-as part of their treatment. Investigators found that 6 of the 522 patients had Lactobacillus bacteremia compared with only 2 of the 21,652 patients who did not receive the LGG probiotic.
The research letter calls for more studies to be done on this matter. A huge international study is now underway that seeks to weigh the risks against the benefits of probiotics in the ICU.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.